| Status: | Phase 3 |
| Entry Type: | Oligosaccharide |
| Molecule Category: | Parent |
| ATC: | B01AB12 |
| UNII: | PUE0TO3XDR |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Coagulation factor X inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Liver Cirrhosis | 3 | D008103 | ClinicalTrials |
| Diabetic Foot | 3 | D017719 | ClinicalTrials |
| Diabetic Angiopathies | 2 | D003925 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Renal Insufficiency | 1 | D051437 | ClinicalTrials |
Related Entries
MCS
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 91449-79-5 |
| ChEMBL | CHEMBL3707365 |
| FDA SRS | PUE0TO3XDR |
CONTENTS